U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077356) titled 'Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma' on July 13.
Brief Summary: The therapeutic options for HCC include hepatectomy, liver transplantation, local ablation therapy, transarterial chemoembolization (TACE), radiotherapy, and systemic therapy. However, as early-stage HCC often presents with no obvious symptoms or atypical clinical manifestations, over 80% of patients are diagnosed at an advanced stage, losing the opportunity for surgical resection and leaving liver transplantation as the only potentially curative option. Nevertheless, even after liver transplantation, the recurrence rate of ...